Rapid Hepatitis C Testing Among Persons at Increased Risk for Infection -- Wisconsin, 2012-2013

Stockman, Lauren J.; Guilfoyle, Sheila M.; Benoit, Andrea L.; Vergeront, James M.; Davis, Jeffrey P.
April 2014
MMWR: Morbidity & Mortality Weekly Report;4/11/2014, Vol. 63 Issue 14, p309
The article discusses the results of a rapid hepatitis C virus (HCV) test conducted for persons at increased risk for infection in Wisconsin from 2012 to 2013. The results include the demographic characteristics of persons who received the test. Injection drug use was found as the most common risk behavior or exposure reported by participants. Also noted are the implications of the findings for public health practice.


Related Articles

  • Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Amon, Joseph J.; Garfein, Richard S.; Ahdieh-Grant, Linda; Armstrong, Gregory L.; Ouellet, Lawrence J.; Latka, Mary H.; Vlahov, David; Strathdee, Steffanie A.; Hudson, Sharon M.; Kerndt, Peter; Jarlais, Don Des; Williams, Ian T. // Clinical Infectious Diseases;6/15/2008, Vol. 46 Issue 12, p1852 

    Objective. To examine hepatitis C virus (HCV) seroprevalence among injection drug users in 4 US cities from 1994 through 2004. Methods. Demographic characteristics, behaviors, and prevalence of HCV antibody among 5088 injection drug users aged 18–40 years from Baltimore, Maryland;...

  • Importance of Quick Test for Screening of Former Drug Users. Gojak, Refet; Ferhatovic, Merdina; Bajramovic, Nermina; Hadzic, Amir; Gazibera, Belma; Bankovic, Dragic // Medicinski Arhiv;2012 Supplement 1, Vol. 66, p30 

    Introduction: Most frequent mode of transmission of HCV today is with intravenous drug use. Former intravenous (IV) drug users present population group more exposed to HCV infection. Longer period of substance abuse, common syringe, more sexual partners (drug users) represent independent,...

  • Hepatitis C Virus Infection: Prevalence, Risk Factors, and Prevention Opportunities among Young Injection Drug Users in Chicago, 1997-1999. Thorpe, Lorna E.; Ouellet, Lawrence J.; Levy, Jennie R.; Williams, Ian T.; Monterroso, Edgar R. // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    The prevalence, risk factors, and prevention opportunities of hepatitis C virus (HCV) in-fection were studied in a large sample of 698 young adult injection drug users (IDUs) in Chicago, 18-30 years old. Participants were recruited between 1997 and 1999 by using street outreach, targeted...

  • HCV reinfection, spontaneous clearance high among injection drug users.  // Infectious Disease News;Dec2013, Vol. 26 Issue 12, p17 

    The article discusses a study on hepatitis C virus reinfection and spontaneous clearance of reinfection among injection drug users in Australia as of December 2013.

  • Reply. Rimland, David; Guest, Jodie L.; Marston, Barbara // Clinical Infectious Diseases;2/1/2000, Vol. 30 Issue 2, p410 

    Responds to comments on a report by C.T. Staples and colleagues, which dealt with hepatitis C virus coinfection. HIV-infection risk factor; Prevalence of both intravenous drug abuse and hepatitis C virus infection.

  • Potential HCV vaccine "highly economically attractive" in Canada.  // PharmacoEconomics & Outcomes News;2/26/2005, Issue 472, p7 

    Discusses research being done on the economic aspects of a potential hepatitis C virus (HCV) vaccine in Canada. Reference to a study by M. D. Krahn and colleagues published in the February 18, 2005 issue of "Vaccine"; Assessment of the cost effectiveness of a potential HCV vaccine; Benefits of...

  • Approach to the Patient with Chronic Hepatitis C Virus Infection. Herrine, Steven K. // Annals of Internal Medicine;5/21/2002, Vol. 136 Issue 10, p747 

    Chronic hepatitis C virus (HCV) infection is common and often asymptomatic. Antibodies against HCV are a highly sensitive marker of infection. Molecular testing for HCV is used to confirm a positive result on antibody testing and to provide prognostic information for treatment; however,...

  • Factors associated with HIV and hepatitis C infection among regular and non-regular injection drug users in Baltimore. Graham, C. M.; Severtson, S. G.; Mitchell, M. M.; Floyd, L.; Latimer, W. W. // Retrovirology;2006 Supplement 1, Vol. 3, pP21 

    The article examines the association of HIV and hepatitis C infection prevalence and the length of time of regular injection drug use in Baltimore, Maryland. Regular users of intravenous drugs were more likely to be infected with hepatitis C virus (HCV) or HIV compared to short term injectors....

  • HCV and HIV Counseling and Testing Integration in California: An Innovative Approach to Increase HIV Counseling and Testing Rates. Stopka, Thomas J.; Marshall, Clark; Bluthenthal, Ricky N.; Webb, David S.; Truax, Steven R. // Public Health Reports;May/Jun2007 Supplement, Vol. 122, p68 

    Objectives. In California, injection drug users (IDUs) comprise the second leading risk group for human immunodeficiency virus (HIV) infection and the majority of hepatitis C virus (HCV) cases. Innovative disease screening and prevention activities are needed to improve disease surveillance and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics